Hepatitis C virus (HCV) is the causative agent of end-stage liver disease. Recent advances in the last decade in anti HCV treatment strategies have dramatically increased the viral clearance rate. However, several limitations are still associated, which warrant a great need of novel, safe and selective drugs against HCV infection. Towards this objective, we explored highly potent and selective small molecule inhibitors, the ellagitannins, from the crude extract of Pomegranate (Punica granatum) fruit peel. The pure compounds, punicalagin, punicalin, and ellagic acid isolated from the extract specifically blocked the HCV NS3/4A protease activity in vitro. Structural analysis using computational approach also showed that ligand molecules interact with the catalytic and substrate binding residues of NS3/4A protease, leading to inhibition of the enzyme activity. Further, punicalagin and punicalin significantly reduced the HCV replication in cell culture system. More importantly, these compounds are well tolerated ex vivo and/`no observed adverse effect level/' (NOAEL) was established upto an acute dose of 5000[emsp14]mg/kg in BALB/c mice. Additionally, pharmacokinetics study showed that the compounds are bioavailable. Taken together, our study provides a proof-of-concept approach for the potential use of antiviral and non-toxic principle ellagitannins from pomegranate in prevention and control of HCV induced complications.
ZnO NPs are promising options due to their versatile application range in almost every field of science and technology including biomedical sciences. Obtaining stable and structured ZnO NPs is still challenging. The aim of this research is to produce highly stable and structured ZnO NPs through an economic and nontoxic approach. For this purpose, a green route using aqueous leaf extract of Plumeria obtusa L. as a reducing agent at different reaction temperatures (t) and annealing temperatures (T) is implemented. The structural, optical, and thermal properties of ZnO NPs were investigated using various analytical techniques (XRD, SEM, TEM, UV-vis, FTIR, Raman, zeta potential, photoluminescence, and TGA) and validated for their biological applications. The increase in both the temperatures ‘t’ and ‘T’ resulted in an increase in crystallite size from 20 to 42 nm with a wurtzite structure and the change was observed from the flower to sphere shape. The zeta-potential values between 35.1 and 47.8 mV suggested higher stability and the excess amount of oxygen over zinc depicted the occurrence of p-type semiconducting behaviour in ZnO NPs. The optical bandgap was found to decrease from 3.48 to 2.96 eV with an increase in ‘t’ and ‘T’ temperatures. More importantly, the ZnO NPs exhibited promising antimicrobial effects on pathogenic bacteria (Klebsiella pneumoniae) and fungi (Aspergillus niger and Rhizopus stolonifer) with inhibition zones of 19 to 26 mm. This study presents an efficient green synthesis route for ZnO NPs with remarkable physicochemical and antimicrobial properties.
A sustainable green synthesis method was utilized to prepare copper-doped zinc oxide (Cu–ZnO) nanoparticles (NPs) using Bixa orellana L. leaf extract as a biogenic reducing and stabilizing agent. The synthesized NPs were characterized by UV–visible spectroscopy, Fourier transform infrared (FTIR) spectroscopy, X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), and transmission electron microscopy (TEM), confirming their spherical morphology, crystalline structure, and particle sizes ranging from 40 to 52 nm. Electrochemical performance evaluated by cyclic voltammetry (CV) on a glassy carbon electrode (GCE) modified with ZnO and Cu–ZnO NPs showed quasi-reversible redox behavior with an increased peak-to-peak separation (ΔE p), indicating slower electron transfer. ZnO-modified GCE exhibited a higher current response over a wider potential range, suggesting superior electrocatalytic activity compared to Cu–ZnO NPs. Antibacterial studies demonstrated effective inhibition against Gram-positive (Bacillus subtilis, Enterococcus faecalis, and Staphylococcus aureus) and Gram-negative (Pseudomonas aeruginosa and Escherichia coli) strains. Cytotoxicity assays revealed dose-dependent anticancer effects against PANC-1 cells, and hemolysis tests confirmed hemocompatibility. Antioxidant activity was validated via the DPPH assay. These multifunctional properties highlight the electrocatalytic and biomedical potential of eco-friendly synthesized Cu–ZnO NPs, emphasizing their promise for therapeutic and electrochemical applications, with ZnO showing superior performance in energy storage.